Skip to content

Supportive Cancer Care Networkers (SCAN)

Supportive Cancer Care Networkers - a Prospective Randomized Controlled Multi-center Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01651832
Acronym
SCAN
Enrollment
261
Registered
2012-07-27
Start date
2012-07-31
Completion date
2015-12-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Chemotherapy

Keywords

Colorectal Neoplasms/*drug therapy/*secondary, Health Services Accessibility, Humans, Supportive Care Needs, Psychooncology, Rural Population, Primary Health Care/*methods, Treatment Outcome, Socioeconomic Factors, Quality Assurance, Health Care, Quality of Life, Adult, Aged, Aged, 80 and over

Brief summary

Aim of the study is to increase the proportion of indicated patients with colorectal cancer undergoing adjuvant chemotherapy following surgical resection through an optimized symptom management and logistical support.

Detailed description

Patients with colorectal cancer in Germany today are exposed to several Problems related to care continuity and access to health care professionals. In order to increase the utilization of adjuvant therapies, patients in the intervention group are offered an additional nursing intervention in the period between discharge after inpatient treatment and the beginning of adjuvant therapy. This includes a telephone follow-up conducted according to guidelines serving to disclose patients' current supportive needs in order to determine potential intervention approaches as early as possible. Hence, the intervention aims to motivate patients not to discontinue the treatment. An early detection of therapy-related physical and psychological impairments aims at optimizing treatment management. Patients in the intervention group therefore are visited by nursing staff specialized in cancer care (Supportive Cancer Care Networkers, SCAN) during their in-patient stay and are informed about the intervention. An assignment for the SCAN is to support patients in getting access to health care services (e.g. specialists). Patients are given certain information, as for example contact to specialists, voluntary services and the next steps and appointments of the treatment plan are discussed. Within a consultation at the day before hospital discharge, the SCAN takes up the contact information and appoints weekly telephone consultations for the time up to the adjuvant therapy. The SCAN hands out information materials and explains the study documents, as for example patient-held records (PHR) in order to improve therapy compliance.

Interventions

BEHAVIORALSCAN

The Supportive Cancer Care Networkers intervention (SCAN) consists of an additional telephone support and symptom-related out-patient care management through Oncology Nursing. The SCAN intervention assesses patients' resources and barriers in utilizing health care services in order to meet their individual needs adequately and supports maintenance of therapy compliance. Thus, the SCAN offers a comprehensive mirroring the patients' medical and psychosocial care needs across changing sectors of health care.

Sponsors

Martin-Luther-Universität Halle-Wittenberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* colorectal carcinoma (ICD-10: C18, C19, C20) * indication for adjuvant chemo therapy following S3-Guideline on colorectal Cancer or physician-directed * living in Saxony-Anhalt * ECOG-Performance Status \<3 * prospective further life expectancy of more than three months

Exclusion criteria

* unable to read or understand German properly * any contra-indication for adjuvant therapy as described in the S3-Guideline such as inadequate liver, bone marrow, and kidney function or coronary heart disease (NYHA III-IV).

Design outcomes

Primary

MeasureTime frame
proportion of eligible patients undergoing adjuvant chemo therapy8 weeks after hospital discharge/ chrirurgical resection

Secondary

MeasureTime frameDescription
Health-related Quality of Life8 weeks & 8 month after hospital discharge/ chrirurgical resectionusing the EORTC QLQ-C30 & CR-29
symptom burden8 weeks & 8 month after hospital discharge/ chrirurgical resectionusing the M.D. Anderson Symptom inventory
disease-free survival8 month after hospital discharge/ chrirurgical resection
supportive care needs8 weeks & 8 month after hospital discharge/ chrirurgical resectionusing the Supportive Needs Questionnaire-37 (FU-T)
Quality of inpatient careat Baselineusing the EORTC INPATSAT-32
Distress8 weeks & 8 month after hospital discharge/ chrirurgical resectionusing the Distress-Thermometer

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026